Daniel J. Lee, MD

ORI 274B

1122 NE 13TH ST


Cost considerations in the management of bladder cancer

October 16, 2017

"We will review the evidence and identify potential areas of improvement that can help reduce costs associated with UCB management while improving outcomes," write Daniel J. Lee, MD, and Sam S. Chang, MD.